Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

← Back to all medicines

Calcium Chloride Injection 10 millimoles in 10 ml

⚠ This medicine appears to have been discontinued

The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.

If you were prescribed this medicine, other products containing Calcium chloride dihydrate may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.

Active substance: Calcium chloride dihydrate
Source: electronic medicines compendium (emc)
Official leaflet: Read the PIL on emc

How to take it

isisused usedfor for • • stomach stomach problems problems Martindale Martindale Pharma 3. 3. How How Calcium Calcium Chloride Chloride Injectionwill willbe begiven given •• irritation irritationininthe theinjected injectedvein vein Bampton BamptonRoad, Road,

  • irritation in the injected vein BamptonPharma Road, Calcium Chloride Chloride isisaasource sourceof ofcalcium, calcium, aachemical chemical essential essential to to Injection Calcium Chloride is a source of calcium,Calcium a chemical essential to Your Your doctor doctorwith will willdilute diluteCalcium CalciumChloride ChlorideInjection Injection with with sodium sodium
  • •• irritation irritation in in the theinjected injectedvein vein Your doctor will dilute Calcium Chloride Injection sodium Bampton Bampton Road, Road, Calcium Calcium Chloride isisaasource source ofofcalcium, calcium, athe achemical chemical essential toto •• severe severeconstipation constipation Harold HaroldHill Hill severe constipation Harold Hill many of ofthe theessential biological biological processes processes within within the thewill body. body. many of Chloride the biological processes withinmany body. Your Your doctor doctor will dilute diluteinfusion Calcium Calcium(0.9% Chloride Chloride Injection Injection with with sodium sodium chloride chloride intravenous intravenous infusion infusion (0.9% (0.9% w/v). w/v). They They will will then then inject inject or or • • severe severe constipation constipation chloride intravenous w/v). They will then inject or Harold Harold Hill Hill many manyofofthe thebiological biologicalprocesses processeswithin withinthe thebody. body. •• loss lossof ofappetite appetite Romford Romford
  • loss of appetite Romford chloride chloride intravenous intravenous infusion infusion (0.9% (0.9% w/v). They They will will then inject injector orslowly infuse infuse (drip) (drip) the theproduct product slowlyinto intoaavein. vein. by any any other other route Calcium CalciumChloride ChlorideInjection Injectionisisused: used:
  • •Use loss loss ofof appetite appetite Romford Romford infuse (drip) the product slowly intow/v). a vein. Use bythen any other route Calcium Chloride Injection is used: •• aametallic metallictaste tasteininthe themouth mouth Essex EssexRM3 RM38UG 8UG •Use a by metallic tasteroute in the mouth Essex RM3 8UG infuse infuse (drip) (drip) the theproduct product slowly slowly into intoaavein. vein. Use Useat by by any any other other route route Calcium Calcium Chloride Chloride Injectionisisused: will willcause cause severe severe irritation irritation and andtissue tissuedamage damage at the the injection injection site. site. •• calcium To Tocorrect correct animbalance imbalance ininthe the level level of ofsevere calcium calcium ininthe the body. body.
  • •• aaat metallic metallic taste taste in in the the mouth mouth Essex Essex RM3 RM3 8UG 8UG will cause irritation and tissue damage the injection site.
  • To correct an Injection imbalance inused: the level of in an the body. •• dry drymouth mouthand andthirst thirst United UnitedKingdom Kingdom dry mouth and thirst United Kingdom will willcause causesevere severeirritation irritationand andtissue tissuedamage damageatatthe theinjection injectionsite. site.
  • • To Tocorrect correctan animbalance imbalanceininthe thelevel levelofofcalcium calciumininthe thebody. body. • • dry dry mouth mouth and and thirst thirst United United Kingdom Kingdom •• tiredness tiredness
  • tiredness Adults Adults(including (includingthe theelderly) elderly) Adults (includingis elderly) Manufacturer: Manufacturer: Manufacturer: 2. 2. Before Before Calcium CalciumChloride Chloride Injection Injection isthe given given •up tiredness 2. Before Calcium Chloride Injection is given Adults Adults (including the the elderly) elderly) •• muscle muscleweakness weakness
  • tiredness muscle weakness
  • An Aninitial initial injection injectionor or infusion infusion (drip) (drip)of of•up to to10 10millimoles millimoles (at (ataa Manufacturer: Manufacturer:
  • An(including initial injection or infusion (drip) •of up to 10 millimoles (at a 2. 2. Before BeforeCalcium CalciumChloride ChlorideInjection Injectionisisgiven given Macarthys MacarthysLaboratories LaboratoriesLtd Ltd Macarthys Laboratories Ltd • • muscle muscle weakness weakness • • An An initial initial injection injection or or infusion infusion (drip) (drip) of of up up to to 10 10 millimoles millimoles (at (at a a •• confusion confusion
  • confusion rate ratenot not exceeding 1millimole millimoleper perminute) minute) may maybe begiven. given.This This DO DOif: NOT NOTuse useCalcium CalciumChloride ChlorideInjection Injection if: if:exceeding 1 millimole per minute) Macarthys Macarthys Laboratories Laboratories Ltd Ltd rate not mayexceeding be given.1This DO NOT use Calcium Chloride Injection Trading Tradingas asMartindale MartindalePharma Pharma Trading as Martindale Pharma ••10 confusion confusion rate not not exceeding exceeding 1millimole millimole per minute) minute) may may be begiven. given. This This DO DO NOTare use use Calcium Calcium Chloridesalts Injection Injection •• high highblood bloodpressure pressure high bloodper pressure may be becontinued continued by by infusion infusionof ofup upto to•10 millimoles millimoles per day. day. ••if:if: you you are are allergic allergic to tocalcium calciumsalts saltsrate or orany any of the theother other1ingredients ingredients Trading Trading as as Martindale Martindale Pharma Pharma may beof continued by infusion per of up tomay 10 millimoles per day.
  • NOT you allergic toChloride calcium or any of the other ingredients Bampton Road, Bampton Road, Bampton Road,
  • •• high high blood blood pressure may may becontinued continuedby byinfusion infusionofofup uptoto10 10millimoles millimolesper perday. day.
  • • you are are allergic allergictoto calcium calcium salts saltsoror6) any anyof of the other ingredients ingredients •• blood bloodclot clotwithin withinthe thevein vein Bampton blood clotpressure within the vein of ofthe this thisother medicine medicine (listed (listedininsection section 6)6) be Bampton Road, Road, ofyou this medicine (listed in section Harold HaroldHill Hill Children Children Harold Hill
  • •• blood blood clot clot within within the thevein vein Children ofthis this medicine medicine (listed (listed ininsection section 6)6) •• you •• muscle muscleor orbone bonepain pain youhave have breathing problems problems or ordangerously dangerouslyfast fastheart heartbeat beat muscle or bone pain Harold Harold Hill Hill
  • of you have breathing problems or dangerously fastbreathing heart beat Children Children Romford Romford 22to to12 12years yearsof ofage: age: Romford • • muscle muscle or or bone bone pain pain 2 to 12 years of age:
  • • you you have have breathing breathing problems problems or or dangerously dangerously fast fast heart heart beat beat • • increase increase in in the the amount amount of of urine urine passed passed (ventricular (ventricularfibrillation) fibrillation) 22toto12
  • increase in the amount of urine passed Romford Romford (ventricular fibrillation) 12years years ofofage: age: Essex EssexRM3 RM38UG 8UG •• 0.5 0.5millimoles millimoles to to3.5 3.5millimoles millimolesby byintravenous intravenous infusion infusion after Essex RM3 8UG
  • •• increase increase inin the theafter amount amount urine urinepassed passed
  • 0.5 millimoles to 3.5 millimoles by intravenous infusion after (ventricular fibrillation) •• calcium calciumdeposits depositsininthe thekidney kidney •• you youhave, have,or orhave haveever everhad, had,kidney kidney stones stones to calcium deposits in theofofkidney Essex Essex RM3 RM3 8UG 8UG
  • (ventricular you have, orfibrillation) have ever had, kidney stones
  • • 0.5 0.5millimoles millimoles 3.5 3.5millimoles millimoles by intravenous intravenous infusion infusion after after44times United UnitedKingdom Kingdom dilution dilution with withchloride at atleast least timesits itsvolume volume of sodium sodium chloride chloride United Kingdom
  • ••of calcium calcium deposits deposits in in the the kidney kidney dilution with attoleast 4 times itsby volume of sodium ••• you you have, have, or or have have ever ever had, had, kidney kidney stones stones • • kidney kidney stones stones • • you you are are aware aware that that you you have have an an excess excess of of calcium calcium in in your your kidney stones United UnitedKingdom Kingdom dilution dilutionwith withatatleast least44times timesits itsvolume volumeintravenous of ofsodium sodiumchloride chloride you are aware that you have an excess of calcium in your intravenous infusion infusion(0.9% (0.9%w/v) w/v)
  • • kidney kidneystones stones intravenous infusion (0.9% w/v)
  • • you youare areaware awarethat thatyou youhave havean anexcess excessof of calcium calcium ininyour your Product Productlicence licencenumber: number: PL PL01883/6174R 01883/6174R blood blood or orurine urine or orare arebeing beingtreated treated for formagnesium magnesium deficiency deficiency Product licence number: PL 01883/6174R Severe Severe andsometimes sometimes fatalside side effects effectslicence have have been been seen seeninin intravenous intravenous infusion infusion (0.9% (0.9%w/v) w/v) blood or urine or are being treated for magnesium deficiency Severe and sometimes fatal side effects haveand been seen in fatal the the dose dose may maybe berepeated repeatedevery everyone oneSevere to tothree three days days Product Product licence number: number: PL PL01883/6174R 01883/6174R •vitamin the dose may be repeated every one•• to three days blood bloodororurine urineororare arebeing beingtreated treatedfor for magnesium magnesium deficiency deficiency This Thisleaflet leafletwas waslast lastrevised revisedin: in:May May2021 2021 Severe and and sometimes sometimes fatal fatal side side effects effects have have been been seen seen in in • • you you suffer suffer from from high high levels levels of of vitamin D D (disorder (disorder known known as as This leaflet was last revised in: May 2021 newborn newborn babies babies ififthey theyhave havebeen been given given Calcium Calcium and and Ceftriaxone. Ceftriaxone.
  • • the thedose dosemay maybe berepeated repeatedevery everyone onetotothree threedays days
  • you suffer from high levels of vitamin D (disorder known as newborn babies if they have been given Calcium and Ceftriaxone. This This leaflet leaflet was was last last revised revised in: in: May May 2021 2021
  • • you yousuffer sufferfrom fromhigh highlevels levelsofofvitamin vitaminDDsarcoidosis) (disorder (disorderknown knownasas newborn newbornbabies babiesififthey theyhave havebeen beengiven givenCalcium Calciumand andCeftriaxone. Ceftriaxone. Under Under22years yearsof ofage: age: sarcoidosis) Under 2 years of age: sarcoidosis) If If any any of of the the side side effects effects get get serious serious or or you you notice notice any any side side effects effects Under22years yearsofofage: age: sarcoidosis) sarcoidosis) Ifinfusion any of the sidedilution effects get serious or you notice any side effects •• less less than than0.5 0.5millimoles millimoles byintravenous intravenous infusion after after •• you youhave haveheart heartproblems problems Under
  • less than 0.5 millimoles by intravenous infusion after dilution by
  • you have heart problems IfIfany any ofofthe the side sidedilution effects effectsget getserious seriousororyou you notice notice any any side side effects effects not not listed listedin in this this leaflet, leaflet, please pleasetell tellyour yourdoctor. doctor.
  • • less less than thanold 0.5 0.5and millimoles millimoles by by intravenous intravenouswith infusion infusion after after dilution
  • • you youhave haveheart heartproblems problems not listed in this leaflet, please tell your doctor. with at atleast least 4intravenous 4dilution times timesits itsvolume volumeof ofsodium sodium chloride chloride intravenous intravenous •• IfIfold the theand patient patient isisaababy baby lessthan than 28 28days days old and isisbeing being given given with at least 4 times its volume of sodium chloride
  • If the patient is a baby less than 28 days is being givenless not not listed listed in in this this leaflet, leaflet, please pleasetell tellyour yourdoctor. doctor. with with at at least least 4 4 times times its its volume volume of of sodium sodium chloride chloride intravenous intravenous
  • • IfIfthe thepatient patientisisaababy babyless lessthan than28 28days days old oldand andChloride is isbeing beingInjection, given given they infusion infusion (0.9% (0.9% w/v) w/v) Reporting Reporting of of side side effects effects Calcium Calcium Chloride Injection, they cannot cannot be be given given Ceftriaxone. Ceftriaxone. infusion (0.9% w/v) Reporting of side effects Calcium Chloride Injection, they cannot be given Ceftriaxone. infusion infusion(0.9% (0.9%w/v) w/v) Reporting of ofside sideeffects effects Calcium CalciumChloride ChlorideInjection, Injection,they theycannot cannotbe begiven givenCeftriaxone. Ceftriaxone.
  • to the the dose dose may maybe berepeated repeatedevery everyone oneReporting to toyou three three days days IfIfdoctor you youget get any any side sideeffects, effects, talk talkto toyour yourdoctor doctoror orpharmacist pharmacistor or the dose may be repeated everyone one•to three days get anyside sideeffects, effects,talk talktoto toyour yourdoctor or pharmacist Warnings Warningsand andprecautions precautions Warnings and precautions ••• the thedose dosemay maybe berepeated repeatedevery every one tothree three days days IfIfIfyou youget get any any side effects, talk your doctor or pharmacist pharmacist or ororpossible nurse. nurse.or This This includes includes any any possibleside sideeffects effectsnot notlisted listedininthis this Warnings Warningsand andprecautions precautions nurse. This includes anypossible possibleside sideeffects effects not listed in this Talk Talk to toyour your doctor doctor or orpharmacist pharmacist before before being being given giventhat Calcium Calcium The The precise precise amount amount that thatyou youare aregiven givendepends depends on onhow how much much Talk to your doctor or pharmacist before being given Calcium The precise amount you are given depends on how much nurse. nurse. This This includes includes any any possible side effects not not listed listed in in this this leaflet. leaflet. You You can can also alsoreport reportside sideeffects effectsdirectly directlyvia viaYellow YellowCard Card Talk Talktotoyour yourdoctor doctorororpharmacist pharmacistbefore before being beinggiven given Calcium Calcium The Theprecise preciseamount amountthat thatyou youare aregiven givendepends depends on onbelieves how howmuch much leaflet. Youcan can alsoreport reportside sideeffects effectsdirectly directly via Yellow Card Chloride Chloride Injection Injection if:if: your your doctor doctor believes you youneed. need.InInthe thecase case of ofchildren children aadoctor doctor Chloride Injection if:if: your doctor believes you need.InIn Inthe thecase case of children doctor leaflet. leaflet. You You can also also report side effects directly via via Yellow Yellow Card Card Scheme. Scheme. Website: Website: www.mhra.gov.uk/yellowcard www.mhra.gov.uk/yellowcard or orsearch searchfor for Chloride ChlorideInjection Injectionif: your your doctor doctor believes believesbreathing you youneed. need. the case ofof children children aadiseases doctor doctor Scheme. Website: www.mhra.gov.uk/yellowcard or search for •• difficulty you youhave havebreathing problems problemswith withyour your lungs lungs or or difficulty difficulty breathing qualified qualified ininthe theadiseases of ofchildren childrenshould should decide decideWebsite: how howmuch much isis •• • you you have problems with your lungs or qualified in the diseases of children should decide how much is Scheme. Scheme. Website: www.mhra.gov.uk/yellowcard www.mhra.gov.uk/yellowcard or or search search for for MHRA MHRA Yellow Yellow Card CardininBy the theGoogle GooglePlay Playor orApple AppleApp AppStore. Store.By By youhave haveproblems problemswith withyour yourlungs lungsor difficulty breathing qualified qualified ininthe thediseases diseasesofofchildren childrenshould should decide decidehow howmuch muchisis MHRAYellow YellowCard Cardinin inthe theGoogle GooglePlay Playoror or Apple App Store. •or
  • difficulty you youhave havebreathing problems problemswith withyour your kidneys kidneys given. given. •• • you you have problems with your kidneys MHRA MHRA Yellow Card the Google Play Apple Apple App App Store. Store. By By given. reporting reporting side side effects, effects,you you canhelp helpprovide providemore moreinformation informationon on youhave haveproblems problemswith withyour yourkidneys kidneys given. given. reportingside sideeffects, effects,you youcan canhelp helpprovide provide more information oncan reporting reporting

Possible side effects

, you can help provide more more information information on on Other Other medicines medicinesand andCalcium CalciumChloride ChlorideInjection Injection the thesafety safety of of this thismedicine. medicine. Other medicines and Calcium Chloride Injection thesafety safetyofof ofthis thismedicine. medicine. Other Othermedicines medicinesand andCalcium CalciumChloride Chloride Injection Injection the the safety this medicine. Tell Tell your your doctor doctor or or pharmacist pharmacist if if you you are are taking, taking, have have recently recently Continued Continuedoverleaf overleaf Tell your doctor or pharmacist you are taking, have recently Continuedoverleaf overleaf Tell Tellyour yourdoctor doctoror orpharmacist pharmacistifififyou youare are taking, taking, haverecently recently Continued Continued overleaf taken taken or orhave might might take takeany anyother othermedicines. medicines. taken or might take any other medicines. taken takenor ormight mighttake takeany anyother othermedicines. medicines. D04002 D04002 D04002

D04002

D04002 D04002

Calcium Chloride 10mmol in 10ml Injection Calcium Calcium Chloride Chloride10mmol 10mmolin in10ml 10mlInjection Injection Calcium CalciumChloride Chloride10mmol 10mmolin in10ml 10mlInjection Injection Calcium Chloride Calcium CalciumChloride Chloride Calcium CalciumChloride Chloride

D04002

How to store it

Calcium Chloride Injection •• feeling feelingsick sick(nausea) (nausea) feeling sick (nausea) Driving Drivingand andusing usingmachines machines Driving and using machines The The injection isissupplied supplied ininampoules colourless colourlessare glass glass ampoules ampoules containing containing 5or 5 5. Howtotostore store Calcium Calcium Chloride Chloride Injection or orsupplied 10 10 ml mlof ofto product. product. The Theampoules ampoules are aresupplied suppliedto toyour yourdoctor doctoror or or injection 10 ml of product. The your doctor

  • •• feeling feeling sick sick(nausea) (nausea) 6.6. Contents Contentsof ofthe thepack packand andother other information information 6.5. How Contents of the pack and otherInjection information Driving Driving and andusing using machines machines •• being beingsick sick(vomiting) (vomiting) being sick (vomiting) Calcium Chloride Chloride may maydizzy make makeyou youdizzy dizzyor ordrowsy. drowsy. IfIfyou you feel feel dizzy dizzy Calcium Chloride may make you dizzy Calcium or drowsy. If you feel or or 10 10 ml ml of of product. product. The The ampoules ampoules are are supplied supplied to to your your doctor doctor or or 6.6. Contents Contentsofofthe thepack packand andother otherinformation information pharmacist pharmacist in in packs packs of of 10 10 ampoules. ampoules. pharmacist in packs of 10 ampoules.
  • •• being being sick sick(vomiting) (vomiting) Calcium Calcium Chloride Chloride may may make make you you dizzy dizzy or or drowsy. drowsy. If If you you feel feel dizzy dizzy • • sweating sweating sweating or ordrowsy drowsy you youshould shouldnot notdrive driveor oroperate operatemachinery. machinery. or drowsy you should not drive or operate machinery. pharmacist pharmacistininpacks packsofof10 10ampoules. ampoules.
  • •• sweating sweating 1. 1. What What Calcium Calcium Chloride Injection Injection isisand and what what it itoperate 1. What Calcium Chloride Injection is and whatChloride it drowsy you youshould should not not drive driveor or operatemachinery. machinery. •• tingling tinglingsensations sensations MarketingAuthorisation AuthorisationHolder: Holder: tingling sensations Marketing Authorisation Holder: Marketing 1. 1. What Calcium Calcium Chloride ChlorideInjection Injection isisand and whatitit orordrowsy
  • •• tingling tingling sensations sensations isisused used for forwhat Marketing Marketing Authorisation Authorisation Holder: Holder: Martindale isWhat used for • • stomach stomach problems problems MartindalePharma Pharma stomach problems Martindale Pharma 3. 3. How How Calcium Calcium Chloride Chloride Injection Injection will will be be given given

About this leaflet

The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.

Medical disclaimer: This page is for information only and does not replace advice from your doctor or pharmacist. Always read the leaflet supplied with your medicine.
Medicines with the same active substance: Calcium chloride dihydrate (39 medicines)
See every medicine containing this substance, or browse the full A–Z of active substances.
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
Technical information intended for healthcare professionals (doctors and pharmacists). The Summary of Product Characteristics (SmPC) is the official document approved by the MHRA/EMA. It does not replace the patient leaflet or a doctor’s advice.

4.1. Therapeutic indications

Hypocalcaemia or electrolyte imbalance

4.2. Posology and method of administration

Posology

For slow intravenous injection or, after dilution with at least 4 times its volume of Sodium Chloride Intravenous Infusion (0.9% w/v), by intravenous infusion.

Adults and the elderly

The precise dosage is determined by the requirements of the patient. Plasma Calcium must be monitored. An initial injection or infusion of up to 10 millimoles (at a rate not exceeding 1 millimole per minute) may be given. This may be continued by infusion of up to 10 millimoles per day.

Paediatric population

The precise dosage is determined by a paediatrician and is dependent on the requirements of the patient. Plasma calcium must be monitored.

Age 2 to 12 years

0.5 millimoles to 3.5 millimoles by intravenous infusion after dilution with at least 4 times its volume of Sodium Chloride Intravenous Infusion 0.9% w/v). The dose may be repeated everyone to three days.

Age: under 2 years

Less than 0.5 millimoles by intravenous infusion after dilution with at least 4 times its volume of Sodium Chloride Intravenous Infusion (0.9% w/v). The dose may be repeated every one to three days.

Method of administration

Intravenous injection or Infusion

4.3. Contraindications

Hypersensitivity to the active substance or to any of the excipients listed in section 6.1

Calcium chloride is also contraindicated in those patients with conditions associated with hypercalcaemia and hypercalcuria (e.g. some forms of malignant disease) or in those with conditions associated with elevated vitamin D levels (e.g. sarcoidosis) or in those with renal calculi or a history of calcium renal calculi.

Ceftriaxone is contraindicated in full-term newborns (up to 28 days of age) if they require (or are expected to require) IV calcium treatment, or calcium-containing infusions because of the risk of precipitation of ceftriaxone-calcium (see sections 4.4 and 4.5).

The treatment of asystole and electromechanical dissociation.

4.4. Special warnings and precautions for use

Cases of fatal reactions with calcium-ceftriaxone precipitates in lungs and kidneys in premature and full-term newborns aged less than 1 month have been described. At least one of them had received ceftriaxone and calcium at different times and through different intravenous lines. In the available scientific data, there are no reports of confirmed intravascular precipitations in patients, other than newborns, treated with ceftriaxone and calcium-containing solutions or any other calcium-containing products.

In patients of any age ceftriaxone must not be mixed or administered simultaneously with any calcium-containing IV solutions, even via different infusion lines or at different infusion sites. However, in patients older than 28 days of age ceftriaxone and calcium-containing solutions may be administered sequentially one after another if infusion lines at different sites are used, or if the infusion lines are replaced or thoroughly flushed between infusions with physiological salt-solution to avoid precipitation. In patients requiring continuous infusion with calcium-containing TPN solutions, healthcare professionals may wish to consider the use of alternative antibacterial treatments which do not carry a similar risk of precipitation. If use of ceftriaxone is considered necessary in patients requiring continuous nutrition, TPN solutions and ceftriaxone can be administered simultaneously, albeit via different infusion lines at different sites. Alternatively, infusion of TPN solution could be stopped for the period of ceftriaxone infusion, considering the advice to flush infusion lines between solutions.

A moderate fall in blood pressure due to vasodilation may attend the injection. Since calcium chloride is an acidifying salt, it is usually undesirable in the treatment of hypocalcaemia of renal insufficiency.

Calcium chloride injection is irritating to veins and must not be injected into tissues, since severe necrosis and sloughing may occur. Great care should be taken to avoid extravasation or accidental injection into perivascular tissues.

Should perivascular infiltration occur, IV administration at that site should be discontinued at once. Local infiltration of the affected area with 1 % procaine hydrochloride, to which hyaluronidase may be added, will often reduce venospasm and dilute the calcium remaining in the tissues locally. Local application of heat may also be helpful.

4.5. Interaction with other medicinal products and other forms of interaction

For interaction between calcium containing products and ceftriaxone, please see sections 4.3 and 4.4 above.

Calcium-containing products may decrease the effectiveness of calcium channel blockers.

Because of the danger involved in the simultaneous use of calcium salts and drugs of the digitalis group, a digitalized patient should not receive an intravenous injection of a calcium compound unless the indications are clearly defined.

Calcium salts should not generally be mixed with carbonates, phosphates, sulfates or tartrate in parenteral mixtures.

The effect of administered magnesium may be neutralised by calcium.

The absorption of tetracyclines is reduced by calcium.

Biphosphonates may interact with calcium chloride causing reduced absorption of biphosphates. Thiazide diuretics may increase the risk of hypercalcaemia.

4.6. Fertility, pregnancy and lactation

Studies on the effects of calcium chloride on pregnant women have not been carried out and problems have not been documented. Calcium crosses the placenta. The benefits of administration must outweigh any potential risk. Calcium is excreted in breast milk but there are no data on the effects, if any, on the infant.

4.7. Effects on ability to drive and use machines

Parenteral calcium can cause dizziness and drowsiness, if affected, patients should not drive or operate machinery.

4.8. Undesirable effects

Rapid intravenous injections may cause the patient to complain of tingling sensations, a calcium taste, and a sense of oppression or “heat wave”. Injections of calcium chloride are accompanied by peripheral vasodilation as well as a local burning sensation and there may be a moderate fall in blood pressure.

Necrosis and sloughing with subcutaneous or intramuscular administration or if extravasation occurs have been reported. Soft tissue calcification, bradycardia or arrhythmias have also been reported.

Hypercalcemia

Rarely, severe, and in some cases fatal, adverse reactions have been reported in preterm and full-term newborns (aged <28 days) who had been treated with intravenous ceftriaxone and calcium. Precipitations of ceftriaxone-calcium salt have been observed in lung and kidneys post-mortem. The high risk of precipitation in newborns is due to their low blood volume and the longer half-life of ceftriaxone compared with adults (see sections 4.3 and 4.4).

Parenteral calcium may cause:

• anorexia

• hypertension

• venous thrombosis

• vomiting

• constipation

• abdominal pain

• muscle weakness

• mental disturbances

• polydipsia

• polyuria

• bone pain

• nephrocalcinosis

• renal calculi

• drowsiness,

• flushing,

• nausea,

• sweating

• mild gastrointestinal disturbances and irritation can occur following intravenous injection.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

4.9. Overdose

Symptoms:

Symptoms: anorexia, nausea, vomiting, constipation, abdominal pain, muscle weakness, mental disturbances, polydipsia, polyuria, bone pain, nephrocalcinosis, renal calculi and, in severe cases, cardiac arrhythmias and coma.

Treatment:

Withholding calcium administration will usually resolve mild hypercalcaemia in asymptomatic patients, provided renal function is adequate.

When serum calcium concentrations are greater than 12mg per 100ml, immediate measures may be required such as hydration, loop diuretics, chelating agents, calcitonin and corticosteroids. Serum calcium concentration should be determined at frequent intervals to guide therapy adjustments.

Cardiac arrhythmia and cardiac arrest may occur.

A diuretic such as bumetanide, ethacrynic acid or frusemide will assist in the excretion of excessive calcium, but in very severe cases, EDTA may be necessary.

💬 Ask about this leaflet

Ask anything about Calcium Chloride Injection 10 millimoles in 10 ml. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.

Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.

Pharmacies in major towns and cities — see the list
Pharmacies by county and region — see the full list

Browse all 2,009 towns and cities →